These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38807062)

  • 21. Participation and yield of a population-based colorectal cancer screening programme in China.
    Chen H; Li N; Ren J; Feng X; Lyu Z; Wei L; Li X; Guo L; Zheng Z; Zou S; Zhang Y; Li J; Zhang K; Chen W; Dai M; He J;
    Gut; 2019 Aug; 68(8):1450-1457. PubMed ID: 30377193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding the impact of colorectal cancer education: a randomized trial of health fairs.
    Briant KJ; Wang L; Holte S; Ramos A; Marchello N; Thompson B
    BMC Public Health; 2015 Nov; 15():1196. PubMed ID: 26621127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies and opportunities to STOP colon cancer in priority populations: pragmatic pilot study design and outcomes.
    Coronado GD; Vollmer WM; Petrik A; Aguirre J; Kapka T; Devoe J; Puro J; Miers T; Lembach J; Turner A; Sanchez J; Retecki S; Nelson C; Green B
    BMC Cancer; 2014 Feb; 14():55. PubMed ID: 24571550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colon capsule endoscopy in colorectal cancer screening: a randomised controlled trial.
    Kaalby L; Deding U; Kobaek-Larsen M; Havshoi AV; Zimmermann-Nielsen E; Thygesen MK; Kroeijer R; Bjørsum-Meyer T; Baatrup G
    BMJ Open Gastroenterol; 2020 Jun; 7(1):. PubMed ID: 32601101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial.
    Rubinstein WS; Acheson LS; O'Neill SM; Ruffin MT; Wang C; Beaumont JL; Rothrock N;
    Genet Med; 2011 Nov; 13(11):956-65. PubMed ID: 22075527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Physician Notification Regarding Nonadherence to Colorectal Cancer Screening on Patient Participation in Fecal Immunochemical Test Cancer Screening: A Randomized Clinical Trial.
    Rat C; Pogu C; Le Donné D; Latour C; Bianco G; Nanin F; Cowppli-Bony A; Gaultier A; Nguyen JM
    JAMA; 2017 Sep; 318(9):816-824. PubMed ID: 28873160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improve the cervical cancer prevention behaviors through mobile-based educational intervention based on I-CHANGE model: study protocol for a randomized controlled trial.
    Kazemi S; Zarei F; Heidarnia A; Alhani F
    Trials; 2022 Sep; 23(1):805. PubMed ID: 36153560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: A pragmatic cluster randomized controlled trial study protocol.
    Clouston K; Katz A; Martens PJ; Sisler J; Turner D; Lobchuk M; McClement S;
    BMC Cancer; 2012 May; 12():182. PubMed ID: 22607726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of a brief phone intervention to increase participation in a population-based colorectal cancer screening programme: a randomized controlled trial.
    Selva A; Torà N; Pascual E; Espinàs JA; Baré M
    Colorectal Dis; 2019 Oct; 21(10):1120-1129. PubMed ID: 31099455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial.
    Forsberg A; Westerberg M; Metcalfe C; Steele R; Blom J; Engstrand L; Fritzell K; Hellström M; Levin LÅ; Löwbeer C; Pischel A; Strömberg U; Törnberg S; Wengström Y; Ekbom A; Holmberg L; Hultcrantz R;
    Lancet Gastroenterol Hepatol; 2022 Jun; 7(6):513-521. PubMed ID: 35298893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and evaluation of mobile application for adolescents' self-care: protocol for a randomized controlled field trial.
    Rezaee R; Ghaffari M; Rabiei R; Kavousi A; Rakhshanderou S
    Trials; 2024 Mar; 25(1):225. PubMed ID: 38549153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer Health Impact Program (CHIP): Identifying Social and Demographic Associations of mHealth Access and Cancer Screening Behaviors Among Brooklyn, New York, Residents.
    Camacho-Rivera M; Rice SL; Oh S; Paris M; Akpara E; Molina J; Obadina M; Mcmillan S; Aracena JLM; Morency J; Muniz RC; Gany F; Brown CL; Gonsky J; Osborne JR
    Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):478-485. PubMed ID: 30733308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial.
    Coronado GD; Vollmer WM; Petrik A; Taplin SH; Burdick TE; Meenan RT; Green BB
    Contemp Clin Trials; 2014 Jul; 38(2):344-9. PubMed ID: 24937017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorectal Cancer: A Collaborative Approach to Improve Education and Screening in a Rural Population
.
    Woodall M; DeLetter M
    Clin J Oncol Nurs; 2018 Feb; 22(1):69-75. PubMed ID: 29350693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Screening of colorectal cancer in Kunming urban residents from 2014 to 2017].
    Zhou H; Zhang X; Shen ZH; Chen XB; Zhao GQ; Lin YP; Huang YC; Zhang Q; Ma J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Nov; 22(11):1058-1063. PubMed ID: 31770837
    [No Abstract]   [Full Text] [Related]  

  • 36. Clusterin in stool: a new biomarker for colon cancer screening?
    Pucci S; Bonanno E; Sesti F; Mazzarelli P; Mauriello A; Ricci F; Zoccai GB; Rulli F; Galatà G; Spagnoli LG
    Am J Gastroenterol; 2009 Nov; 104(11):2807-15. PubMed ID: 19623170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developing Patient-Refined Messaging for a Mailed Colorectal Cancer Screening Program in a Latino-Based Community Health Center.
    Thompson JH; Davis MM; Michaels L; Rivelli JS; Castillo ML; Younger BM; Castro M; Reich SL; Coronado GD
    J Am Board Fam Med; 2019; 32(3):307-317. PubMed ID: 31068395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
    Sharma T
    Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nurse-led reinforced education by mobile messenger improves the quality of bowel preparation of colonoscopy in a population-based colorectal cancer screening program: A randomized controlled trial.
    Lam TYT; Wu PI; Tang RSY; Tse YK; Lau JYW; Wu JCY; Sung JJY
    Int J Nurs Stud; 2022 Sep; 133():104301. PubMed ID: 35764027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of screening using annual fecal immunochemical test alone versus combined with one-time colonoscopy in reducing colorectal cancer mortality: the Akita Japan population-based colonoscopy screening trial (Akita pop-colon trial).
    Saito H; Kudo SE; Takahashi N; Yamamoto S; Kodama K; Nagata K; Mizota Y; Ishida F; Ohashi Y
    Int J Colorectal Dis; 2020 May; 35(5):933-939. PubMed ID: 32034490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.